Centene's 2024 outlook hampered by Medicaid redeterminations
Healthcare
Stay updated with breaking news from Andrew Asher. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Opinion: Tariffs on some Chinese amino acids should be extended for the sake of American food and economic security, writes Andrew Asher.
Medicare Advantage and Part D Star Ratings declined this year, and while that was expected, the poor showing by Centene was somewhat of a surprise, with Executive Vice President and Chief Financial Officer Andrew Asher saying during a recent earnings call that the company "has a lot of work" to do to change the star ratings around. Only four plans received a low 2-star rating,
By Raghav Mahobe and Nandhini Srinivasan (Reuters) -Centene Corp on Tuesday said profit at its fast-growing Medicare Advantage (MA) business will take a beating in 2024 due to a sharp cut in its rating by
Operator: Good day, and welcome to the Centene Fourth Quarter Earnings Conference Call. . Please note, today's event is being recorded.